Delivery Order SPE2DB24D2216-SPE2DB25FGPTK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $9,973.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical product, with an ultimate completion date of July 30, 2025. This is a non-set-aside award issued on July 29, 2025, with fulfillment based at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $19,447.53 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of TALTZ 80 MG/ML auto-injector (2-pack) pharmaceutical products. This firm fixed-price delivery order, which concludes on August 15, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.24 on August 20, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with a completion date of August 21, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,628.66 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued on August 14, 2025, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,780.47 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies. This firm fixed price contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $24,715.91 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies on September 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor specializing in federal medical...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPTKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,237.44 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector supply on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement fulfilled through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract portfolio with DLA demonstrates its role as a critical vendor for federal medical procurement, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 9/9/25 |